Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
about
TB vaccine development and the End TB Strategy: importance and current status.Transformative tools for tackling tuberculosisTuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosisDissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional modelStrategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational StudyMulti-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection.Towards new TB vaccines: What are the challenges?Experimental study of tuberculosis: From animal models to complex cell systems and organoids.Anti-Infectious Human Vaccination in Historical Perspective.Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients.Design of tuberculosis vaccine trials under financial constraints.What can immunology contribute to the control of the world's leading cause of death from bacterial infection?Evaluation of Aggregated Ag85B Antigen for Its Biophysical Properties, Immunogenicity, and Vaccination Potential in a Murine Model of Tuberculosis Infection.CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains.A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection.Mycobacterium tuberculosis Protein Rv3841 Activates Dendritic Cells and Contributes to a T Helper 1 Immune Response.The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
P2860
Q26748621-6FD383CD-55B7-4123-A60E-064CD5D1A4A2Q26784084-65CABC34-A4D4-4D2D-ADEF-861F59EB0E8BQ28079851-15415A17-11E5-4347-B72E-861B22B51201Q28468572-8AFF2240-52ED-4E9B-B8A0-06E7A4C77CAFQ28603191-AD02E708-345D-4A57-901D-791806F9CD69Q33614952-78417205-093C-4EBE-AC7B-68BC0CC880EDQ33719289-C5DDC4CC-E520-4373-BCEC-023CD932CD3BQ36074922-A06DE280-9412-4D7C-918A-A2432100B51AQ36338571-600B8E36-8113-444A-888F-86572BA8F1A3Q37397323-E9B48060-02C4-4F23-8CA9-8984690C54BFQ38767468-EF9BFF91-7A51-4F8F-9497-FC74352F823CQ40089850-458DB1DA-18B7-4E46-9B50-D8838E39A9CFQ40129444-48D448EE-2B97-4DB5-8958-18E24F7D6C3CQ40382721-1257FFA4-3D2F-457D-9443-72FF269896FCQ40383030-6E8FE3ED-954A-4C54-A816-6FBC89D2E424Q40714734-6E2D6457-63E3-41A5-A4AF-91C30F7F3B80Q41471050-B5DDB4A9-B61A-4C9F-9507-080DB04FDF01Q47100509-73441A45-1DB6-46A8-8B2A-A4CB568F5994Q47828181-AD3C8FBD-2875-4189-A436-FC3DA946ECC5Q52655450-D4704755-A1F9-47FD-B65D-025AA747F3DEQ54111708-D6BC796A-1B68-4F2A-AED4-3D1FFA2744E0Q58765317-ED1A9715-5403-4224-AE3B-B230333297BD
P2860
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@ast
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@en
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@nl
type
label
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@ast
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@en
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@nl
prefLabel
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@ast
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@en
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@nl
P2860
P3181
P356
P1476
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
@en
P2093
Christopher B Wilson
Lynda M Stuart
P2860
P304
P3181
P356
10.1111/IMR.12270
P407
P5008
P577
2015-03-01T00:00:00Z